Please assess the completion status of the following clinical trial:

Trial Title: To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pre-menopausal woman, between her 18th and 39th birthday, receiving recombinant FSH as stimulation for IVF and/or ICSI~* Subjects who were able to communicate well with the investigator and to comply with the requirements of the entire study~* Subjects who had given written informed consent, prior to treatment, with the understanding that consent may be withdrawn by the subject at any time without prejudice~Exclusion Criteria:~* Subjects who had known allergic reaction against one of the ingredients~* Subjects with enlarged ovaries or cysts unrelated to polycystic ovaries (PCO)~* Subjects with gynaecological bleeding of unknown origin~* Subjects who had ovarian, uterine, or mammary cancer~* Subjects with tumors of the hypothalamus or the pituitary gland

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 39 Years
- Healthy Volunteers: f

Study Arms:
- Gonal-f (Type: EXPERIMENTAL): None
- Puregon (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).